RENEO PHARMACEUTICALS INC (RPHM)
Institutional ownership reported to the SEC as of Q4 2025, across 15 quarters.
1
Reporting holders
$1.5K
Reported value
0.0%
Held as options
-47
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Torren Management, LLC | $1.5K | 504 | 0.00% | new | FIRST |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 1 | $1.5K | 504 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 48 | $49.1M | 28,827,877 | 4 | 16 | 15 | 0.2% |
| Q2 2024 | 64 | $42.2M | 27,816,797 | 19 | 14 | 19 | 0.2% |
| Q1 2024 | 60 | $45.3M | 27,131,553 | 12 | 13 | 17 | 0.7% |
| Q4 2023 | 67 | $44.1M | 24,785,009 | 25 | 15 | 15 | 10.0% |
| Q3 2023 | 54 | $205.0M | 26,923,145 | 11 | 22 | 10 | 0.0% |
| Q2 2023 | 48 | $164.8M | 25,598,825 | 19 | 17 | 5 | 0.0% |
| Q1 2023 | 30 | $100.1M | 16,768,193 | 7 | 7 | 4 | 0.0% |
| Q4 2022 | 24 | $37.6M | 16,120,747 | 2 | 4 | 4 | 0.0% |
| Q3 2022 | 32 | $55.1M | 16,459,366 | 4 | 7 | 8 | 0.0% |
| Q2 2022 | 30 | $43.3M | 16,381,101 | 6 | 5 | 9 | 0.0% |
| Q1 2022 | 41 | $50.8M | 17,293,298 | 4 | 7 | 13 | 0.0% |
| Q4 2021 | 39 | $148.9M | 17,413,721 | 4 | 14 | 5 | 0.0% |
| Q3 2021 | 38 | $136.7M | 18,367,963 | 5 | 9 | 11 | 0.0% |
| Q2 2021 | 37 | $170.6M | 18,300,692 | 37 | 0 | 0 | 0.0% |